Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: A randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group

S Daenen, Ronnie van der Holt, GEG Verhoef, Bob Löwenberg, PW Wijermans, PC Huijgens, M van Marwijk Kooy, HC Schouten, MHH Kramer, A Ferrant, E van den Berg, MMC Steijaert, LF Verdonck, Pieter Sonneveld

Research output: Contribution to journalArticleAcademicpeer-review

37 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1057-1067
Number of pages11
JournalLeukemia Research
Volume28
DOIs
Publication statusPublished - 2004

Cite this